$-1.08
(Market cap
$10 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
300.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
64,532,100
10 Years Aggregate
CFO
$-345.41 Mln
EBITDA
$-402.04 Mln
Net Profit
$-435.02 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GlycoMimetics (GLYC)
| -41.3 | -40.8 | -45.7 | -38.4 | -38.1 | -45.3 | -32.7 |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
GlycoMimetics (GLYC)
| -89.3 | -22.1 | 110.4 | -61.7 | -28.9 | -44.1 | -43.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout GlycoMimetics (GLYC)
GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.
-
CEO, President & Director
Mr. Harout Semerjian
-
CEO, President & Director
Mr. Harout Semerjian
-
Headquarters
Monrovia, MD
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for GlycoMimetics (GLYC)
What is the current share price of GlycoMimetics Inc (GLYC) Today?
The share price of GlycoMimetics Inc (GLYC) is $14.62 (NASDAQ) as of 18-Jun-2025 09:30 EDT. GlycoMimetics Inc (GLYC) has given a return of -38.13% in the last 3 years.
What is the current PB & PE ratio of GlycoMimetics Inc (GLYC)?
Since, TTM earnings of GlycoMimetics Inc (GLYC) is negative, P/E ratio is not available.
The P/B ratio of GlycoMimetics Inc (GLYC) is 300.17 times as on 18-Jun-2025, a 5511 premium to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
What is the 52 Week High and Low of GlycoMimetics Inc (GLYC)?
The 52-week high and low of GlycoMimetics Inc (GLYC) are Rs -- and Rs -- as of 28-Aug-2026.
What is the market cap of GlycoMimetics Inc (GLYC)?
GlycoMimetics Inc (GLYC) has a market capitalisation of $ 10 Mln as on 18-Jun-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in GlycoMimetics Inc (GLYC)?
Before investing in GlycoMimetics Inc (GLYC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.